腹腔镜不够:全程ERAS依从是结肠癌术后短期结局改善的关键
单中心观察性研究纳入320例择期腹腔镜结肠癌切除患者,比较引入ERAS路径前后各160例。平均总住院时间ERAS组5.8天,短于标准组的8.2天(p<0.01);再入院率与吻合口并发症无差异。
要点
- ERAS路径可降低腹腔镜结肠癌切除术后总体并发症发生率
- ERAS组平均总住院时间较标准组缩短
- 再入院率与吻合口并发症未见差异
核心结论
- 在择期腹腔镜结肠癌切除患者中,ERAS路径降低总体并发症发生率并缩短住院时间,且不增加再入院率。
- 并发症下降主要来自非手术并发症的显著减少,手术并发症未见显著减少。
研究设计与样本
- 单中心观察性研究,数据来自前瞻性维护数据库。
- 纳入择期腹腔镜结肠癌切除患者320例,按ERAS引入前(标准组)与引入后(ERAS组)各160例分组。
- 主要终点为术后90天并发症发生率,次要终点包括总住院时间、再入院率及ERAS方案依从性。
主要发现
- 两组基线特征无差异。
- ERAS组平均总住院时间为5.8天,标准组为8.2天(p<0.01)。
- 两组再入院率与吻合口并发症无差异。
- 总体并发症差异并非来自主要并发症的减少。
临床怎么用
- 在腹腔镜结肠癌切除的基础上应推行全程ERAS路径以改善短期结局。
- 关注ERAS对非手术并发症的减少作用,手术并发症管理仍需单独加强。
局限性
- 单中心观察性研究,非随机分组,可能存在混杂与时间偏倚。
- 样本量有限(320例),结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The enhanced recovery after surgery (ERAS) programs and laparoscopic techniques both reduce hospital stay and postoperative morbidity in patients undergoing colorectal cancer surgery. Laparoscopic techniques are an integral part of the ERAS program. However, evidence showing that the implementation of a multimodal rehabilitation program in addition to laparoscopy for colonic cancer would improve postoperative outcomes is still lacking. This study aimed to evaluate the impact of ERAS program on postoperative outcomes after elective laparoscopic colonic cancer resection. METHODS: This is a single-center observational study from a prospectively maintained database. Two groups were formed from all patients undergoing laparoscopic colonic surgery for neoplasm during a defined period before (standard group) and after introduction of an ERAS program (ERAS group). The primary endpoint was postoperative 90-day morbidity. Secondary endpoints were the total length of hospital stay, readmission rate, and compliance with ERAS protocol. RESULTS: A total of 320 patients were included in the analyses, with 160 patients in the standard group and 160 in the ERAS group. There were no differences in the baseline characteristics between the two groups. Overall morbidity was significantly lower in the ERAS group (21.25%) than that in the standard group (34.4%; OR = 0.52 [0.31-0.85], p < 0.01). This difference was not due to the reduction in major complications. Mean total hospital stay was significantly lower in the ERAS group (5.8 days) than that in the standard group (8.2 days, p < 0.01). There were no differences in readmission rates and anastomotic complications. CONCLUSIONS: The ERAS pathway reduced the overall morbidity rates and shortened the length of hospital stay, without increasing the readmission rates. A significant reduction in nonsurgical complications was evident, whereas no significant reduction was found for surgical complications.
引用
- Meillat H, Brun C, Zemmour C, et al. Laparoscopy is not enough: full ERAS compliance is the key to improvement of short-term outcomes after colectomy for cancer. Surg Endosc. 2019. PMID: 31385073. doi:10.1007/s00464-019-06987-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。